Company attributes
Other attributes
Zennea is a company primarily known for developing a clinical, therapeutic wearable product for chronic snoring and mild obstructive sleep apnea (OSA). The company was founded in 2016 by Nell Du, Oliver Luo, Rachel Chase, and Ryan Threlfall, in Surrey, British Columbia, Canada.
The company has created a medical device for snorers and people with mild OSA, and that connects to and is controlled by a mobile app that can be adjusted to the user's daily routine. The device is wireless, hose-less, and comes without a machine, and rests under the chin. The purpose of the device is to reduce or remove obstructive sleep apnea.
Their ZENS product is seeking authorization from the FDA and is being put through clinical trials. The company has provided a ZENS demonstration of how the product removes airway blockage.
The company participated and raised money in four funding rounds including pre-seed, convertible note, seed, and another convertible note round. Some of their investors include SOSV and HAX.
